Raphael E. Pollock
2Patents
1h-index
9Co-inventors
30Inventor score
Filing activity: Sep 10, 2004 → Dec 4, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7316907B2 | 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types | Chemistry; Metallurgy | 10 | Expired |
| US7709205B2 | 14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.